Valo Health

Computational platform for drug discovery/development


HBM contact: Dr Andreas Wicki

Company status: private

Valo created an active-learning integrated drug discovery and development engine, spanning the entire R&D lifecycle. Valo’s platform has the potential to deliver breakthrough medicines at far less cost and with fewer failures. In doing so it combines data unrivaled in size, depth and fidelity with real-world evidence, human insights, and machine learning to feed an integrated system driven by massive compute power. Valo identifies molecules and predicts their chances for success for the right patient populations at an unprecedented pace.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171